GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.
Ciardullo S, Morieri ML, Daniele G, Fiorentino TV, Mezza T, Tricò D, Consoli A, Del Prato S, Giorgino F, Piro S, Solini A, Avogaro A.
Ciardullo S, et al. Among authors: solini a.
Acta Diabetol. 2024 Jun 3. doi: 10.1007/s00592-024-02300-6. Online ahead of print.
Acta Diabetol. 2024.
PMID: 38831203
Review.